Treatment Overview
Cyclo G6 MicroPulse Laser Therapy in Korea is a cutting-edge, non-incisional Minimally Invasive Glaucoma Surgery (MIGS) option designed to safely reduce intraocular pressure (IOP) by modulating the ciliary body—the structure responsible for producing aqueous humor. Unlike traditional continuous-wave cyclophotocoagulation, MicroPulse technology divides laser energy into ultra-short pulses, allowing targeted treatment while keeping surrounding tissues protected.
Korean ophthalmology centers combine the Cyclo G6 platform with AI-based energy mapping, real-time thermal monitoring, ocular ultrasound guidance, and personalized glaucoma profiles to provide safe, effective, and repeatable IOP reduction with minimal discomfort and no incisions.
This procedure is especially valued for its excellent safety profile, quick recovery, and versatility in various stages of glaucoma.
Purpose & Benefits
Purpose
- Reduce aqueous humor production by gently modulating ciliary body activity.
- Safely lower intraocular pressure in patients with mild to severe glaucoma.
- Provide a non-incisional alternative when medications or MIGS alone are insufficient.
- Offer a repeatable, long-term treatment option with minimal tissue disruption.
Benefits
- Non-Invasive: No incision, sutures, or implants required.
- High Safety Margin: MicroPulse technology prevents tissue overheating and damage.
- Effective IOP Reduction: Works for both early and advanced glaucoma cases.
- Minimal Discomfort: Low inflammation and quick postoperative recovery.
- Repeatable Treatment: Can be safely repeated for enhanced pressure control.
- Medication Reduction: Many patients reduce dependence on glaucoma drops.
- Suitable for a Broad Range of Patients: Effective even for complex or refractory cases.
Ideal Candidates
Cyclo G6 MicroPulse Laser Therapy in Korea is ideal for:
- Patients with mild, moderate, or severe glaucoma seeking a non-incisional option.
- Individuals with medication intolerance or poor adherence.
- Patients who have limited response to other MIGS, laser procedures, or filtering surgeries.
- Individuals with previous ocular surgeries, including trabeculectomy and drainage implants.
- High-risk patients for whom incisional surgery carries increased risk.
- Patients needing a safe, repeatable method of long-term IOP control.
Possible Risks & Complications
MicroPulse technology significantly reduces traditional risks, but mild effects may occur:
- Temporary discomfort or redness
- Mild inflammation
- Transient blurred vision
- Short-term IOP fluctuations
- Rare prolonged hypotony or inflammation
Korean surgeons minimize risks by applying AI-adjusted energy dose modeling, thermal safety algorithms, and imaging-guided anatomical assessment prior to treatment.
Surgical Techniques
AI-Calibrated Treatment Planning
AI software calculates ideal laser power, duty cycle, and exposure time based on glaucoma severity and ocular anatomy.
MicroPulse Laser Modulation
Laser energy is delivered in rapid pulses to safely modulate ciliary body function without coagulative damage.
Contour Probe Application
A specially designed transscleral probe is used to distribute energy evenly and comfortably.
Real-Time Thermal Control
Ensures the laser does not overheat or damage surrounding tissues.
Ultrasound/OCT Pre-Mapping
Provides precise visualization of ciliary body position for targeted therapy.
Treatment Process in Korea
Step-by-Step Workflow
Step 1 – Comprehensive Glaucoma Evaluation
Includes IOP measurements, OCT, visual field analysis, and AI-based treatment planning.
Step 2 – Pre-Treatment Preparation
Topical anesthesia is applied; no incisions or injections are required.
Step 3 – MicroPulse Laser Delivery
The Cyclo G6 probe delivers controlled MicroPulse energy over the ciliary body region.
Step 4 – Post-Treatment Assessment
Surgeons evaluate early IOP response and overall comfort.
Treatment Duration: 5–8 minutes per eye
Setting: Outpatient, non-incisional procedure
Recovery & After-Care
After-Care Guidelines
- Use anti-inflammatory drops for 1–2 weeks as recommended.
- Avoid heavy exercise or eye rubbing for a few days.
- Normal daily activities can typically resume immediately.
- Continue glaucoma medication unless directed otherwise.
- Attend follow-up visits at Day 1, Week 1, and Month 1.
Recovery Timeline
Day 1: Mild irritation possible; early pressure response begins.
Week 1: Significant improvement in comfort and IOP control.
Weeks 2–4: Stable IOP reduction; medication taper may begin.
1–3 Months: Full stabilization and long-term drainage balance.
Results & Longevity
Expected Results
- Noticeable and stable IOP reduction.
- Improved outflow balance through reduced aqueous production.
- Medication reduction in many patients.
- Repeatable without major risk.
Longevity
- Results typically last months to several years, depending on glaucoma severity.
- Repeat treatments enhance long-term IOP control.
- Korean clinics maintain long-term success through AI-guided dosing and personalized follow-up.
Why Korea Is a Top Destination
- Advanced Laser Expertise: Korean surgeons are global leaders in MicroPulse glaucoma therapy.
- AI-Driven Personalization: Customized energy algorithms for each patient.
- Non-Invasive Treatment Models: Excellent for elderly or high-risk individuals.
- Cutting-Edge Imaging: OCT and ultrasound used for pre-planning and evaluation.
- Rapid Recovery & Comfort: Minimal downtime and outstanding patient satisfaction.
Unique Korean Innovations
- AI-based MicroPulse dose optimization.
- Thermal safety monitoring with real-time feedback.
- Custom treatment arcs tailored to canal and ciliary body anatomy.
- Integration with hybrid MIGS programs for combined pressure reduction.
- Long-term IOP tracking with deep-learning progression analysis.
These enhancements make Cyclo G6 MicroPulse Laser Therapy in Korea one of the safest, most effective, and most advanced non-incisional MIGS treatments available today.
Cost Range (Indicative Estimate)
| Treatment Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Standard MicroPulse Session | ₩700,000 – ₩1,100,000 | ~$520 – $820 | Single-session MicroPulse treatment with basic IOP monitoring |
| Premium AI-Guided MicroPulse Package | ₩1,200,000 – ₩1,900,000 | ~$900 – $1,400 | AI-calibrated dosing, OCT pre-planning, extended follow-up |
| Advanced Glaucoma Management Program | ₩2,000,000 – ₩3,500,000+ | ~$1,500 – $2,600+ | Multi-session therapy, hybrid MIGS strategies, long-term monitoring |
Final pricing depends on clinic, equipment, and surgeon expertise.
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul): Leaders in MicroPulse glaucoma therapy and advanced laser protocols.
- Dream Eye Center (Seoul): Known for AI-guided laser dosing and safe non-incisional glaucoma care.
- BGN Eye Clinic (Seoul & Busan): Specialists in mixed-modality MIGS and MicroPulse laser treatment.
- Glory Seoul Eye Clinic: Focuses on precision laser therapy and long-term monitoring.
- K-Cure Vision Center (Gangnam): Experts in minimally invasive glaucoma management with advanced imaging support.
